Vaxart, Inc.: cash_and_equivalents
| Value | {"amount": 11506000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2018-12-31) |
| Status | current |
| Entity | Vaxart, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:09:58.901789+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/56a12d50-983a-4af4-9c1d-ddcdf87b7c07
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001513162-19-000041 · Open the official SEC filing →Retrieved: 2026-08-19T07:09:58.901789+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000072444/cash-and-equivalents/2018-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/56a12d50-983a-4af4-9c1d-ddcdf87b7c07
History
- no predecessors — first report